 |
Prospector
Profile
07.1422
|
| |
| Qmed, Inc. |
NAICS |
518210 |
| 25 Christopher Way
Eatontown, NJ 07724 |
Description |
Data Management Services |
| (732) 544-5544 |
Employees |
104 |
| http://www.qmedinc.com/ |
Revenue |
(mil) |
9.8800 |
| |
Income |
(mil) |
-14.2400 |
| |
Assets |
(mil) |
20.8100 |
| |
Liability |
(mil) |
5.8000 |
| |
(for the year ended 2006-11-30) |
| |
|
Category:
Loss/Deficit
|
| |
|
Event:
Qmed, Inc. reported a $9,201,399 net loss on $10,781,247 of revenues for the third quarter ended Aug. 31, 2007, compared with a $3,317,401 net loss on $2,202,270 of revenues for the same period ended Aug. 31, 2006. At Aug. 31, 2007, the Company's consolidated balance sheet showed $16,364,268 in total assets, $12,974,993 in total liabilities, and $3,389,275 in total stockholders' equity. The Company's balance sheet at Aug. 31, 2007, showed strained liquidity with $10,031,611 in total current assets and $12,661,404 in total current liabilities.
|
| |
|
Intellectual Property:
The Company maintains a policy of seeking patent protection in the United States and other countries in connection with certain elements of its technology. The Monitor One technology has been granted patents in the United States (Patent No. 4679144), Canada (Patent No. 1281081), and Spain (Patent No. 547040). The Company received a U.S. patent for the nDx technology on March 29, 1994 (Patent No. 5299119) and a patent for the ohms/cad system (Patent No. 5,724,580) on March 3, 1998. Certain patents relating to its technology began expiring in 2004. In October 2006, QMed filed an application for a patent for certain elements of its technology related to the collection of medical information and its identification in relation to patient diagnoses. [SEC Filing 10-K 02-13-07]
|
| |
|
Description:
The Company provides evidence-based clinical information management systems around the country to its health plan customers. The system incorporates Disease Management services to patients and decision support to physicians. The Company's QMedCare subsidiary specializes in serving high-risk populations of Medicare beneficiaries.
|
| |
|
Officers:
Michael W. Cox (CEO); Jane A. Murray (COO); William T. Schmitt Jr., CPA (CFO); Teri J. Kraf R.N., MHA. (SR. VP)
|
| |
|
Auditor:
Amper Politziner & Mattia PC
|
| |
|
Securities:
Common Stock Symbol QMED; NasdaqCM;
17,051,765 common shares outstanding as of Oct. 3, 2007.
|
| |
| |
| |
| return to main page |
|
|
